Literature DB >> 23608953

[Implantable cardioverter defibrillator].

C Stellbrink1, D Andresen, D Böcker, T Lewalter.   

Abstract

This article aims to give an overview over important articles in the field of implantable cardioverter defibrillator (ICD) therapy in 2012. Important publications concern analyses on therapy efficacy and safety of the subcutaneous ICD, gender-specific differences in the complication rate and prognosis after ICD implantation, the necessity of intraoperative testing of the defibrillation threshold and the impact of preventive measures to reduce ICD therapies on prognosis after device implantation. The relevance of the study findings for daily clinical practice is briefly discussed.

Entities:  

Mesh:

Year:  2013        PMID: 23608953     DOI: 10.1007/s00399-013-0265-7

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  18 in total

1.  Evaluation oF FactORs ImpacTing CLinical Outcome and Cost EffectiveneSS of the S-ICD: design and rationale of the EFFORTLESS S-ICD Registry.

Authors:  Susanne S Pedersen; Pier Lambiase; Lucas V A Boersma; Francis Murgatroyd; Jens Brock Johansen; Helen Reeve; A Graham Stuart; Pedro Adragao; Dominic A M J Theuns
Journal:  Pacing Clin Electrophysiol       Date:  2012-02-23       Impact factor: 1.976

2.  Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study.

Authors:  Maurizio Landolina; Giovanni B Perego; Maurizio Lunati; Antonio Curnis; Giuseppe Guenzati; Alessandro Vicentini; Gianfranco Parati; Gabriella Borghi; Paolo Zanaboni; Sergio Valsecchi; Maurizio Marzegalli
Journal:  Circulation       Date:  2012-05-24       Impact factor: 29.690

3.  Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: the START study.

Authors:  Michael R Gold; Dominic A Theuns; Bradley P Knight; J Lacy Sturdivant; Rick Sanghera; Kenneth A Ellenbogen; Mark A Wood; Martin C Burke
Journal:  J Cardiovasc Electrophysiol       Date:  2011-10-28

4.  Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy.

Authors:  Louise R A Olde Nordkamp; Reinoud E Knops; Gust H Bardy; Yuri Blaauw; Lucas V A Boersma; Johannes S Bos; Peter Paul H M Delnoy; Pascal F H M van Dessel; Antoine H G Driessen; Joris R de Groot; Jean Paul R Herrman; Luc J L M Jordaens; Kirsten M Kooiman; Alexander H Maass; Mathias Meine; Yuka Mizusawa; Sander G Molhoek; Jurjen van Opstal; Jan G P Tijssen; Arthur A M Wilde
Journal:  Am Heart J       Date:  2012-05       Impact factor: 4.749

5.  The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts.

Authors:  George H Crossley; Andrew Boyle; Holly Vitense; Yanping Chang; R Hardwin Mead
Journal:  J Am Coll Cardiol       Date:  2011-01-20       Impact factor: 24.094

6.  A randomized-controlled pilot study comparing ICD implantation with and without intraoperative defibrillation testing in patients with heart failure and severe left ventricular dysfunction: a substudy of the RAFT trial.

Authors:  Jeff S Healey; Lorne J Gula; David H Birnie; Lawrence Sterns; Stuart J Connolly; John Sapp; Eugene Crystal; Chris Simpson; Derek V Exner; Teresa Kus; Francois Philippon; George Wells; Anthony S L Tang
Journal:  J Cardiovasc Electrophysiol       Date:  2012-07-12

7.  Automatic remote monitoring of implantable cardioverter-defibrillator lead and generator performance: the Lumos-T Safely RedUceS RouTine Office Device Follow-Up (TRUST) trial.

Authors:  Niraj Varma; Justin Michalski; Andrew E Epstein; Robert Schweikert
Journal:  Circ Arrhythm Electrophysiol       Date:  2010-08-17

8.  The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort.

Authors:  Louise R A Olde Nordkamp; Lara Dabiri Abkenari; Lucas V A Boersma; Alexander H Maass; Joris R de Groot; Antonie J H H M van Oostrom; Dominic A M J Theuns; Luc J L M Jordaens; Arthur A M Wilde; Reinoud E Knops
Journal:  J Am Coll Cardiol       Date:  2012-10-10       Impact factor: 24.094

9.  Prognostic importance of defibrillator shocks in patients with heart failure.

Authors:  Jeanne E Poole; George W Johnson; Anne S Hellkamp; Jill Anderson; David J Callans; Merritt H Raitt; Ramakota K Reddy; Francis E Marchlinski; Raymond Yee; Thomas Guarnieri; Mario Talajic; David J Wilber; Daniel P Fishbein; Douglas L Packer; Daniel B Mark; Kerry L Lee; Gust H Bardy
Journal:  N Engl J Med       Date:  2008-09-04       Impact factor: 91.245

10.  Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.

Authors:  Hamid Ghanbari; Ghassan Dalloul; Reema Hasan; Marcos Daccarett; Souheil Saba; Shukri David; Christian Machado
Journal:  Arch Intern Med       Date:  2009-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.